From Dallas, Texas, at a meeting of the American Heart Association
A drug called levosimendan, in combination with standard drugs, eases symptoms in patients hospitalized for heart failure better than do those drugs alone, scientists report. Heart failure, which affects 5 million people in the United States, is marked by the organ's inability to beat vigorously. Patients with the condition often experience shortness of breath, shakiness, weakness, and sweating.
In the new study, researchers identified 600 such patients whose symptoms had gotten so bad that they were admitted to hospitals, in the United States, Australia, and Israel. All received standard medical care. To start the study, half also got a 24-hour infusion of levosimendan, and half got a placebo infusion.
Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.